Skip to content
Dx

ICD-10-CM 2027 diagnosis code

D89.4Mast cell activation syndrome and related disorders

Not billable — use a more specific code

D89.4 is a header code, so it can't be reported by itself. Choose one of the 6 more specific codes beneath it.

Code last changed in FY2017 (effective October 1, 2016). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About D89.4

D89.4 is the ICD-10-CM diagnosis code for mast cell activation syndrome and related disorders. It belongs to category D89 (other disorders involving the immune mechanism, not elsewhere classified), block D80-D89 (certain disorders involving the immune mechanism) and chapter 3 (diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism). It is a header code, so it can't be reported by itself; one of its 6 subcodes must be used instead.

Within D89 (other disorders involving the immune mechanism, not elsewhere classified), D89.4 is specifically for mast cell activation syndrome and related disorders. Related codes cover Polyclonal hypergammaglobulinemia (D89.0), Cryoglobulinemia (D89.1), hypergammaglobulinemia, unspecified (D89.2), immune reconstitution syndrome (D89.3), other specified disorders involving the immune mechanism, not elsewhere classified (D89.8) and disorder involving the immune mechanism, unspecified (D89.9).

To report this condition, pick the subcode that matches the documentation: D89.40 (unspecified), D89.41 (syndrome), D89.42 (syndrome), D89.43 (activation), D89.44 (tryptasemia) and D89.49 (disorder).

Don't report D89.4 together with the conditions in its Excludes1 note: aggressive systemic mastocytosis (C96.21), congenital cutaneous mastocytosis (Q82.2), (non-congenital) cutaneous mastocytosis (D47.01), (indolent) systemic mastocytosis (D47.02) and 7 more.

It was added in FY2017, effective October 1, 2016.

Specific codes under D89.4

Coding notes

Excludes1Not coded here — never report together with this code
  • aggressive systemic mastocytosis (C96.21)
  • congenital cutaneous mastocytosis (Q82.2)
  • (non-congenital) cutaneous mastocytosis (D47.01)
  • (indolent) systemic mastocytosis (D47.02)
  • malignant mast cell neoplasm (C96.2-)
  • malignant mastocytoma (C96.29)
  • mast cell leukemia (C94.3-)
  • mast cell sarcoma (C96.22)
  • mastocytoma NOS (D47.09)
  • other mast cell neoplasms of uncertain behavior (D47.09)
  • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)

Notes that apply from higher levels

Instructions written at a parent level also apply to D89.4.

› From D89 Other disorders involving the immune mechanism, not elsewhere classified
Excludes1
  • hyperglobulinemia NOS (R77.1)
  • monoclonal gammopathy (of undetermined significance) (D47.2)
Excludes2
  • transplant failure and rejection (T86.-)

Broader instructions also apply from D80-D89 Certain disorders involving the immune mechanism and Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2017 (effective 10/1/2016): Added
  • No changes since FY2017.

Common questions about D89.4

Is D89.4 billable?

No. D89.4 is a header code. Report one of its more specific subcodes instead.